Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

Bullboard Posts

Comment by attila9on Feb 04, 2004 2:58pm

230 Views

Post# 7001526

RE: Sucker Rally

Yes.Perpertrated by the brokerage houses.They win we lose again.Always a good time to pump up a junior stock right after the AGM to make investors think there are bigger & better things to come.Especially when nobody attended the AGM.I still think this will do alright if HK goes well.I'm hanging in until final trial completed next week.What have i got to lose.I bet some of the long took some shares off the table also.jmo

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading